About
Palm Therapeutics has developed a proprietary high-throughput screening platform to identify molecules that modulate protein palmitoylation, enabling the development of targeted therapeutics for diseases including pan-NRAS-mutant cancers.
Explore Palm Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.